New House bill would cut tax deductions pharma companies receive for ads
A bipartisan piece of legislation proposed this week would prohibit pharma companies from receiving tax deductions for direct-to-consumer drug advertising, a bill that could generate …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.